{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:42:57Z","timestamp":1790880177650,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ajog.2015.07.044","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T23:34:47Z","timestamp":1438817687000},"page":"31-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["The medical management of abnormal uterine bleeding in reproductive-aged women"],"prefix":"10.1016","volume":"214","author":[{"given":"Linda D.","family":"Bradley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndeye-Aicha","family":"Gueye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.07.044_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1586\/17474108.4.2.179","article-title":"Health-related quality of life and economic burden of abnormal uterine bleeding","volume":"4","author":"Fraser","year":"2009","journal-title":"Exp Rev Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/jwh.2013.4288","article-title":"Abnormal uterine bleeding, health status, and usual source of medical care: analyses using the Medical Expenditures Panel Survey","volume":"22","author":"Matteson","year":"2013","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2015.07.044_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.whi.2008.07.002","article-title":"STOP-DUB Research Group. Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment","volume":"19","author":"Frick","year":"2009","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.ajog.2015.07.044_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2015.07.044_bib5","series-title":"Clinical gynecologic endocrinology and infertility","first-page":"242","year":"2012"},{"key":"10.1016\/j.ajog.2015.07.044_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0015-0282(16)31742-3","article-title":"The effect of age upon the pattern of the menstrual cycle","volume":"5","author":"Collett","year":"1954","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.07.044_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jama.1968.03140060001001","article-title":"The length and variability of the human menstrual cycle","volume":"203","author":"Chiazze","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2015.07.044_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1471-0528.1984.tb04831.x","article-title":"Normal variation in the length of the luteal phase of the\u00a0menstrual cycle: identification of the short luteal phase","volume":"91","author":"Lenton","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1471-0528.1984.tb04830.x","article-title":"Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age","volume":"91","author":"Lenton","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib10","first-page":"73","article-title":"Patterns of menstrual loss in menorrhagia","author":"Haynes","year":"1979","journal-title":"Res Clin Forums"},{"key":"10.1016\/j.ajog.2015.07.044_bib11","first-page":"775","article-title":"Pituitary and ovarian hormone levels in unexplained menorrhagia","volume":"84","author":"Eldred","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/humupd\/8.1.60","article-title":"Mechanisms of abnormal uterine bleeding","volume":"8","author":"Livingstone","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2015.07.044_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1479-828X.1985.tb00621.x","article-title":"Prostaglandin inhibitors in gynaecology","volume":"25","author":"Fraser","year":"1985","journal-title":"Aust N Z J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.soard.2005.02.008","article-title":"Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass","volume":"1","author":"Eid","year":"2005","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.ajog.2015.07.044_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0015-0282(16)35047-6","article-title":"Clinical and biochemical features of polycystic ovarian disease","volume":"14","author":"Goldzieher","year":"1963","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.07.044_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2015.07.044_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.07.044_bib18","series-title":"Clinical Gynecologic Endocrinology and Infertility","first-page":"242","year":"2012"},{"key":"10.1016\/j.ajog.2015.07.044_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0015-0282(16)46571-4","article-title":"Effect of body weight reduction on plasma androgens in obese, infertile women","volume":"38","author":"Bates","year":"1982","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.07.044_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2015.07.044_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0015-0282(16)56632-1","article-title":"Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women","volume":"61","author":"Guzick","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.07.044_bib22","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2015.07.044_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0002-9378(96)70680-4","article-title":"Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium","volume":"174","author":"Widrich","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.AOG.0000130065.49187.c8","article-title":"Detection of benign endometrial masses by endometrial stripe measurement in premenopausal women","volume":"104","author":"Breitkopf","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib25","first-page":"553","article-title":"Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer","volume":"40","author":"Guido","year":"1995","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2015.07.044_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S1074-3804(00)80041-9","article-title":"Accuracy of preoperative diagnostic tools and outcome of hysteroscopic management of menstrual dysfunction","volume":"7","author":"Pasqualotto","year":"2000","journal-title":"J\u00a0Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.ajog.2015.07.044_bib27","first-page":"285","article-title":"Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding\u2014a double-blind randomized controlled study","volume":"59","author":"DeVore","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/01.AOG.0000238343.62063.22","article-title":"Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial","volume":"108","author":"Munro","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib29","doi-asserted-by":"crossref","first-page":"304.e1","DOI":"10.1016\/j.ajog.2014.11.031","article-title":"Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative","volume":"212","author":"Corona","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0b013e3181beab47","article-title":"Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial","volume":"114","author":"Kaunitz","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2008.11.011","article-title":"Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen of oral contraceptives","volume":"79","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2015.07.044_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mob.2002.121103","article-title":"Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel\/ethinyl estradiol","volume":"186","author":"Bjarnad\u00f3ttir","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib33","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib35","first-page":"CD000154","article-title":"Oral contraceptive pill for heavy menstrual bleeding","author":"Farquhar","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.07.044_bib36","first-page":"913","article-title":"Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding","volume":"96","author":"Davis","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A\u00a0multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2015.07.044_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cct.2003.08.008","article-title":"Medicine or surgery (Ms): a randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding","volume":"25","author":"Varner","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2015.07.044_bib40","first-page":"453","article-title":"Pharmacological therapy for abnormal uterine bleeding","volume":"18","author":"Pinkerton","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2015.07.044_bib41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0002-9378(93)90269-O","article-title":"A\u00a0comparative study of danazol, a regimen of decreasing doses of danazol and norethindrone in the treatment of objectively proven unexplained menorrhagia","volume":"169","author":"Higham","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib42","first-page":"CD001016","article-title":"Cyclical progestogens for heavy menstrual bleeding","author":"Lethaby","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.07.044_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1479-828X.1990.tb02028.x","article-title":"Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens","volume":"30","author":"Fraser","year":"1990","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0015-0282(16)39669-8","article-title":"Contraceptive use\u2014efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days","volume":"24","author":"Schwallie","year":"1973","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.07.044_bib45","series-title":"Depo Provera [package insert]","year":"2013"},{"key":"10.1016\/j.ajog.2015.07.044_bib46","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh869","article-title":"Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis","volume":"20","author":"Petta","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2015.07.044_bib47","first-page":"347","article-title":"Levonorgestrel intrauterine system: a first-line medical treatment for heavy menstrual bleeding","volume":"6","author":"Nelson","year":"2010","journal-title":"Womens Health"},{"key":"10.1016\/j.ajog.2015.07.044_bib48","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jmig.2009.04.018","article-title":"The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy","volume":"16","author":"Vilos","year":"2009","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib49","first-page":"CD002126","article-title":"Progesterone or progesterone-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.07.044_bib50","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bpobgyn.2007.03.023","article-title":"Modern management of abnormal uterine bleeding\u2014the levonorgestrel intra-uterine system","volume":"21","author":"Mansour","year":"2007","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib51","first-page":"690","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib52","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/AOG.0b013e3181a1d3ce","article-title":"Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis","volume":"113","author":"Kaunitz","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00001703-200110000-00006","article-title":"Dysfunctional uterine bleeding: advances in diagnosis and treatment","volume":"13","author":"Munro","year":"2001","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib54","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1471-0528.1998.tb10172.x","article-title":"Randomised comparative trial of\u00a0the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia","volume":"105","author":"Irvine","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib55","first-page":"57","article-title":"Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel-releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers","volume":"35","author":"K\u00fc\u00e7\u00fck","year":"2008","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib56","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1701-2163(16)34151-2","article-title":"A\u00a0Canadian, multicenter study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia","volume":"31","author":"Endrikat","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2015.07.044_bib57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2010.06.011","article-title":"Levonorgestrel-releasing intrauterine system compared to low-dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial","volume":"83","author":"Shaaban","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2015.07.044_bib58","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-0528.2005.00642.x","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss, and pictorial blood loss assessment charts","volume":"112","author":"Reid","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2015.07.044_bib59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0010-7824(82)90145-7","article-title":"Body iron stores and patterns of bleeding after insertion of a levonorgestrel or a copper-releasing intrauterine device","volume":"26","author":"Heikkila","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2015.07.044_bib60","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(02)04913-0","article-title":"Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia","volume":"79","author":"Xiao","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.07.044_bib61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"ECLIPSE Trial Collaborative Group. Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.07.044_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-0528.2006.00863.x","article-title":"A\u00a0randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding","volume":"113","author":"Busfield","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2015.07.044_bib63","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial\u00a05-year follow-up","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2015.07.044_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1074-3804(00)80005-5","article-title":"Abnormal uterine bleeding in the reproductive years. Part II\u2014medical management","volume":"7","author":"Munro","year":"2000","journal-title":"J\u00a0Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.ajog.2015.07.044_bib65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(00)03615-1","article-title":"Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a\u00a0randomised trial","volume":"357","author":"Hurskainen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.07.044_bib66","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1471-0528.1980.tb04489.x","article-title":"Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo","volume":"87","author":"Chimbira","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib67","series-title":"Danazol. In: Martindale: The Complete Drug Reference","year":"2013"},{"key":"10.1016\/j.ajog.2015.07.044_bib68","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/pgmj.67.791.833","article-title":"A\u00a0comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia","volume":"67","author":"Bonduelle","year":"1991","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajog.2015.07.044_bib69","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1471-0528.1989.tb03325.x","article-title":"Comparison between mefenamic acid and danazol in the treatment of established menorrhagia","volume":"96","author":"Dockeray","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/01443618709068521","article-title":"Danazol in menorrhagia: a double-blind placebo-controlled trial","volume":"7","author":"Lamb","year":"1987","journal-title":"J\u00a0Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib71","first-page":"CD001017","article-title":"Danazol for heavy menstrual bleeding","author":"Beaumont","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.07.044_bib72","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.fertnstert.2008.08.017","article-title":"Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age","volume":"92","author":"Luisi","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.07.044_bib73","first-page":"311","article-title":"Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy","volume":"33","author":"Warnock","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.ajog.2015.07.044_bib74","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijgo.2008.10.032","article-title":"Gonadotropin-releasing hormone analog combined with a low-dose oral contraceptive to treat heavy menstrual bleeding","volume":"104","author":"Cetin","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2015.07.044_bib75","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.ogx.0000259228.70277.6f","article-title":"Medical therapies for chronic menorrhagia","volume":"62","author":"Nelson","year":"2007","journal-title":"Obstet Gynecol Surv"},{"issue":"Suppl 14","key":"10.1016\/j.ajog.2015.07.044_bib76","first-page":"18","article-title":"Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids","volume":"103","author":"Thomas","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib77","first-page":"CD000547","article-title":"Preoperative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.07.044_bib78","first-page":"720","article-title":"Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind placebo-controlled, multicenter study. The Leuprolide Study Group","volume":"77","author":"Friedman","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib79","first-page":"212","article-title":"Short-term use of Goserelin depot in the treatment of dysfunctional uterine bleeding","volume":"22","author":"Colacurci","year":"1995","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib80","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1471-0528.1981.tb01009.x","article-title":"Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding","volume":"88","author":"Smith","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib81","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0002-9378(93)90292-Q","article-title":"Nonsteroidal antiinflammatory drugs and reproduction","volume":"169","author":"Dawood","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib82","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1471-0528.1976.tb00839.x","article-title":"Studies on the involvement of prostaglandins in uterine symptomatology and pathology","volume":"83","author":"Willman","year":"1976","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5122(03)00068-9","article-title":"Pathophysiology of endometrial bleeding","volume":"45","author":"Ferenczy","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.ajog.2015.07.044_bib84","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1471-0528.1987.tb03150.x","article-title":"Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid","volume":"94","author":"Hall","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl 11","key":"10.1016\/j.ajog.2015.07.044_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1471-0528.1994.tb13690.x","article-title":"Assessment of medical treatments for menorrhagia","volume":"101","author":"Shaw","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib86","first-page":"CD000400","article-title":"Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding","author":"Lethaby","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.07.044_bib87","first-page":"000400","article-title":"Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4 Pt 1","key":"10.1016\/j.ajog.2015.07.044_bib88","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0002-9378(87)80093-5","article-title":"Treatment of menorrhagia with meclofenamate sodium","volume":"157","author":"Vargyas","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib89","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.287.6394.703","article-title":"Prostaglandins and menstrual disorders","volume":"287","author":"Elder","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/j.ajog.2015.07.044_bib90","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2165\/00003495-200363130-00008","article-title":"Tranexamic acid: a review of its use in the management of menorrhagia","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ajog.2015.07.044_bib91","first-page":"141","article-title":"The effect of tranexamic acid on bleeding time and haemostasis","volume":"34","author":"Menzies","year":"1991","journal-title":"Neurochirurgia (Stuttg)"},{"key":"10.1016\/j.ajog.2015.07.044_bib92","first-page":"27","article-title":"The\u00a0haemostatic system and dysfunctional uterine bleeding","volume":"5","author":"Bonnar","year":"1983","journal-title":"Res Clin Forums"},{"key":"10.1016\/j.ajog.2015.07.044_bib93","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1471-0528.1993.tb14272.x","article-title":"Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding","volume":"100","author":"Gleeson","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib94","first-page":"1","article-title":"Tranexamic acid therapy: effective treatment in heavy menstrual bleeding. Clinical update on safety","volume":"4","author":"Rybo","year":"1991","journal-title":"Ther Adv"},{"key":"10.1016\/j.ajog.2015.07.044_bib95","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bmj.4.5729.214","article-title":"Treatment of menorrhagia with tranexamic acid. A double-blind trial","volume":"4","author":"Callender","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.ajog.2015.07.044_bib96","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1471-0528.1995.tb10881.x","article-title":"Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161)","volume":"102","author":"Edlund","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib97","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2011.05.015","article-title":"A\u00a0dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding","volume":"205","author":"Freeman","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib98","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/00016349409023453","article-title":"The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding","volume":"73","author":"Gleeson","year":"1994","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2015.07.044_bib99","first-page":"CD000249","article-title":"Antifibrinolytics for heavy menstrual bleeding","author":"Lethaby","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.07.044_bib100","first-page":"163","article-title":"Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding","volume":"36","author":"Gultekin","year":"2009","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib101","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.313.7057.579","article-title":"Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid","volume":"313","author":"Bonnar","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2015.07.044_bib102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1471-0528.1995.tb11293.x","article-title":"Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia","volume":"102","author":"Preston","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib103","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/AOG.0b013e3181f20177","article-title":"Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Lukes","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib104","first-page":"347","article-title":"Society of Obstetrics and Gynaecology of Canada. Canadian contraception consensus","volume":"26","author":"Black","year":"2004","journal-title":"J\u00a0Obstet Gyaecol Can"},{"key":"10.1016\/j.ajog.2015.07.044_bib105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0015-0282(16)61022-1","article-title":"A\u00a0randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy","volume":"52","author":"Friedman","year":"1989","journal-title":"Fertil Steril"},{"issue":"Suppl 3","key":"10.1016\/j.ajog.2015.07.044_bib106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/humrep\/11.suppl_3.33","article-title":"GnRH analogues in the treatment of uterine fibroids","volume":"11","author":"Golan","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2015.07.044_bib107","first-page":"856","article-title":"A\u00a0placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata","volume":"74","author":"Schlaff","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib108","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1469-0705.1998.11040283.x","article-title":"Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid","volume":"11","author":"Lakhani","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib109","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/PAS.0b013e318032125e","article-title":"Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas","volume":"31","author":"Ip","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2015.07.044_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","volume":"31","author":"Singh","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajog.2015.07.044_bib111","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.07.044_bib112","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.07.044_bib113","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.07.044_bib114","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12325-012-0042-8","article-title":"Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids","volume":"29","author":"Talaulikar","year":"2012","journal-title":"Adv Ther"},{"key":"10.1016\/j.ajog.2015.07.044_bib115","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice: uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2 Pt 1","key":"10.1016\/j.ajog.2015.07.044_bib116","first-page":"387","article-title":"ACOG Practice Bulletin: Alternatives to hysterectomy in the management of leiomyomas","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib117","first-page":"CD005073","article-title":"Uterine artery embolization for symptomatic uterine fibroids","author":"Gupta","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.07.044_bib118","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1933719113497289","article-title":"Magnetic resonance-guided focused ultrasound myomectomy: safety, efficacy, subsequent fertility and quality-of-life improvements, a systematic review","volume":"21","author":"Gizzo","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2015.07.044_bib119","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jmig.2014.02.015","article-title":"Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas","volume":"21","author":"Berman","year":"2014","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib120","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/AOG.0b013e3181c33c72","article-title":"Choosing the route of hysterectomy for benign disease. ACOG Committee opinion no. 444","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib121","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V63.3.657.657","article-title":"Estrogen stimulates von Willebrand factor production by cultured endothelial cells","volume":"63","author":"Harrison","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2015.07.044_bib122","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.AOG.0000431815.52679.bb","article-title":"Management of abnormal uterine bleeding associated with ovulatory dysfunction. ACOG Practice bulletin no. 136","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.07.044_bib123","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2516.2007.01611.x","article-title":"Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin","volume":"14","author":"Rodeghiero","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.ajog.2015.07.044_bib124","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2015.07.044_bib125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2010.12.011","article-title":"Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation","volume":"84","author":"Huq","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2015.07.044_bib126","series-title":"Medical eligibility criteria for contraceptive use: a WHO family planning cornerstone","year":"2010"},{"key":"10.1016\/j.ajog.2015.07.044_bib127","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2006-949665","article-title":"Women and von Willebrand disease: controversies in diagnosis and management","volume":"32","author":"Kadir","year":"2006","journal-title":"Semin Thromb Hemost"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815008455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815008455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:06:39Z","timestamp":1757588799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815008455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0002937815008455"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.07.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The medical management of abnormal uterine bleeding in reproductive-aged women","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}